Skip to content

Clinical trials

Phase 3 Obesity trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 3 Country / region: Mexico Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20071
20081
20112
20161
20171
20182
20193
20212
20224
20238
20244
20259
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting16
Active, not recruiting7
Terminated4
Unknown status4
Not yet recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company20
Novo Nordisk A/S14
Coordinación de Investigación en Salud, Mexico3
Pfizer3
Sanofi3
Amgen2
Boehringer Ingelheim2
Hoffmann-La Roche2
Carnot Laboratories1
Centro Universitario de Ciencias de la Salud, Mexico1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity53
Overweight26
Diabetes Mellitus, Type 27
Nutrition Disorders7
Cardiovascular Diseases3
Sleep Apnea, Obstructive3
Diabetes Mellitus2
Diabetes Mellitus, Type 12
Heart Failure2
Overnutrition2

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.